Bo Ding
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
β-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: July 22, 2026
WTAP-Mediated Glutaminase Splicing Bias Suppresses Ferroptosis in Hepatocellular Carcinoma.
Journal: Cancer communications (London, England)
Published: November 09, 2025
Efficacy of Hepatic Artery Infusion Chemotherapy with Bevacizumab and Sintilimab in Advanced Hepatocellular Carcinoma: A Case Report.
Journal: The American journal of case reports
Published: June 07, 2025
Advances in improving the efficacy of anti-PD-1/PD-L1 therapy in intrahepatic cholangiocarcinoma.
Journal: Critical reviews in oncology/hematology
Published: April 21, 2025
MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer.
Journal: International journal of oncology
Published: January 26, 2024
N6 -methyladenosine-modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide.
Journal: Clinical and translational medicine
Published: June 23, 2023
ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation.
Journal: Journal of translational medicine
Published: February 05, 2023
Amino acid metabolism in health and disease.
Journal: Signal transduction and targeted therapy
Published: January 10, 2023
Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 14, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026